GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biosyent Inc (OTCPK:BIOYF) » Definitions » Cyclically Adjusted PB Ratio

BIOYF (Biosyent) Cyclically Adjusted PB Ratio : 5.32 (As of May. 30, 2025)


View and export this data going back to . Start your Free Trial

What is Biosyent Cyclically Adjusted PB Ratio?

As of today (2025-05-30), Biosyent's current share price is $8.5642. Biosyent's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $1.61. Biosyent's Cyclically Adjusted PB Ratio for today is 5.32.

The historical rank and industry rank for Biosyent's Cyclically Adjusted PB Ratio or its related term are showing as below:

BIOYF' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 4.16   Med: 7.26   Max: 48.29
Current: 5.08

During the past years, Biosyent's highest Cyclically Adjusted PB Ratio was 48.29. The lowest was 4.16. And the median was 7.26.

BIOYF's Cyclically Adjusted PB Ratio is ranked worse than
83.31% of 683 companies
in the Drug Manufacturers industry
Industry Median: 1.88 vs BIOYF: 5.08

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Biosyent's adjusted book value per share data for the three months ended in Mar. 2025 was $2.229. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.61 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biosyent Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Biosyent's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyent Cyclically Adjusted PB Ratio Chart

Biosyent Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.70 6.33 4.28 4.75 4.95

Biosyent Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.30 4.75 4.95 4.95 4.82

Competitive Comparison of Biosyent's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biosyent's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biosyent's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biosyent's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Biosyent's Cyclically Adjusted PB Ratio falls into.


;
;

Biosyent Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Biosyent's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=8.5642/1.61
=5.32

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biosyent's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Biosyent's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=2.229/129.1809*129.1809
=2.229

Current CPI (Mar. 2025) = 129.1809.

Biosyent Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.585 100.500 0.752
201509 0.612 100.421 0.787
201512 0.632 99.947 0.817
201603 0.709 101.054 0.906
201606 0.785 102.002 0.994
201609 0.842 101.765 1.069
201612 0.871 101.449 1.109
201703 0.915 102.634 1.152
201706 1.006 103.029 1.261
201709 1.166 103.345 1.458
201712 1.199 103.345 1.499
201803 1.249 105.004 1.537
201806 1.321 105.557 1.617
201809 1.403 105.636 1.716
201812 1.423 105.399 1.744
201903 1.418 106.979 1.712
201906 1.351 107.690 1.621
201909 1.405 107.611 1.687
201912 1.448 107.769 1.736
202003 1.398 107.927 1.673
202006 1.445 108.401 1.722
202009 1.541 108.164 1.840
202012 1.634 108.559 1.944
202103 1.738 110.298 2.036
202106 1.856 111.720 2.146
202109 1.862 112.905 2.130
202112 1.963 113.774 2.229
202203 2.038 117.646 2.238
202206 2.073 120.806 2.217
202209 2.034 120.648 2.178
202212 2.030 120.964 2.168
202303 2.019 122.702 2.126
202306 2.091 124.203 2.175
202309 2.160 125.230 2.228
202312 2.207 125.072 2.279
202403 2.197 126.258 2.248
202406 2.231 127.522 2.260
202409 2.378 127.285 2.413
202412 2.178 127.364 2.209
202503 2.229 129.181 2.229

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biosyent  (OTCPK:BIOYF) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Biosyent Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Biosyent's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biosyent Business Description

Traded in Other Exchanges
Address
2476 Argentia Road, Suite 402, Toronto, Mississauga, ON, CAN, L5N 6M1
Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.m.

Biosyent Headlines

From GuruFocus

Q1 2023 Biosyent Inc Earnings Presentation Transcript

By GuruFocus Research 02-12-2024

Q2 2021 Biosyent Inc Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2020 Biosyent Inc Earnings Call Transcript

By GuruFocus Research 02-12-2024

BioSyent Declares Second Quarter 2025 Dividend

By GlobeNewswire 05-15-2025

Q3 2022 Biosyent Inc Earnings Presentation Transcript

By GuruFocus Research 02-12-2024

Q1 2019 Biosyent Inc Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2020 Biosyent Inc Earnings Call Transcript

By GuruFocus Research 02-12-2024

Biosyent Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 02-12-2024